- Filed
- Mar 4, 2022 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2021 · Feb 17, 2022 | 39.24M sh |
| Shares Diluted | FY 2021 · Dec 31, 2021 | 39.69M sh |
| Shares Diluted restated | FY 2021 · Dec 31, 2020 | 38.12M sh |
| Shares Diluted restated | FY 2021 · Aug 31, 2020 | 91.42M sh |
| Shares Diluted restated | FY 2021 · Dec 31, 2019 | 91.29M sh |
| Operating Cash Flow | FY 2021 · Dec 31, 2021 | $740.24M |
| Operating Cash Flow | FY 2021 · Dec 31, 2020 | $82.17M |
| Operating Cash Flow | FY 2021 · Aug 31, 2020 | $112.61M |
| Operating Cash Flow | FY 2021 · Dec 31, 2019 | $755.96M |
| Long Term Debt | FY 2021 · Dec 31, 2021 | $0 |
| Long Term Debt | FY 2021 · Dec 31, 2020 | $360M |
| Long Term Debt | FY 2021 · Sep 1, 2020 | $425.33M |
| Cash And Equivalents | FY 2021 · Dec 31, 2021 | $41.25M |
| Cash And Equivalents | FY 2021 · Dec 31, 2020 | $25.61M |
| Cash And Equivalents | FY 2021 · Sep 1, 2020 | $22.66M |
| Stockholders Equity | FY 2021 · Dec 31, 2021 | $1.66B |
| Stockholders Equity | FY 2021 · Dec 31, 2020 | $1.23B |
| Stockholders Equity | FY 2021 · Sep 1, 2020 | $1.19B |
| Current Liabilities | FY 2021 · Dec 31, 2021 | $637.73M |
| Current Liabilities | FY 2021 · Dec 31, 2020 | $321.99M |
| Current Liabilities | FY 2021 · Sep 1, 2020 | $345.73M |
| Total Liabilities | FY 2021 · Dec 31, 2021 | $794.31M |
| Total Liabilities | FY 2021 · Dec 31, 2020 | $815.14M |
| Total Liabilities | FY 2021 · Sep 1, 2020 | $953.51M |
| Current Assets | FY 2021 · Dec 31, 2021 | $338.27M |
| Current Assets | FY 2021 · Dec 31, 2020 | $190.42M |
| Current Assets | FY 2021 · Sep 1, 2020 | $207.58M |
| Total Assets | FY 2021 · Dec 31, 2021 | $2.46B |
| Total Assets | FY 2021 · Dec 31, 2020 | $2.04B |
| Total Assets | FY 2021 · Sep 1, 2020 | $2.14B |
| Eps Diluted | FY 2021 · Dec 31, 2021 | $10.78 |
| Eps Diluted | FY 2021 · Dec 31, 2020 | $1.03 |
| Eps Diluted | FY 2021 · Aug 31, 2020 | −$43.37 |
| Eps Diluted | FY 2021 · Dec 31, 2019 | −$2.64 |
| Eps Basic | FY 2021 · Dec 31, 2021 | $10.97 |
| Eps Basic | FY 2021 · Dec 31, 2020 | $1.03 |
| Eps Basic | FY 2021 · Aug 31, 2020 | −$43.37 |
| Eps Basic | FY 2021 · Dec 31, 2019 | −$2.64 |
| Sga Expense | FY 2021 · Dec 31, 2021 | $49.52M |
| Sga Expense | FY 2021 · Dec 31, 2020 | $21.73M |
| Sga Expense | FY 2021 · Aug 31, 2020 | $91.82M |
| Sga Expense | FY 2021 · Dec 31, 2019 | $132.61M |
| Operating Income | FY 2021 · Dec 31, 2021 | $441.61M |
| Operating Income | FY 2021 · Dec 31, 2020 | $34.98M |
| Operating Income | FY 2021 · Aug 31, 2020 | −$4.19B |
| Operating Income | FY 2021 · Dec 31, 2019 | $12.67M |
| Revenue | FY 2021 · Dec 31, 2021 | $1.53B |
| Revenue | FY 2021 · Dec 31, 2020 | $273.36M |
| Revenue | FY 2021 · Aug 31, 2020 | $459M |
| Revenue | FY 2021 · Dec 31, 2019 | $1.57B |